In managing an exacerbation of COPD with increased purulent sputum production, what is the recommended treatment?

In the management of an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), particularly when there is an increase in purulent sputum, the use of antibiotics is highly recommended. The presence of purulent sputum suggests a bacterial infection, which is a common trigger for acute exacerbations in patients with COPD. In these situations, antibiotics can help address the underlying infection and reduce the severity and duration of the exacerbation.

Antibiotics are effective in treating bacterial infections, which can lead to increased mucus production and inflammation in the airways. Addressing the bacterial component can improve symptoms and potentially prevent further complications.

Inhaled corticosteroids are generally used for long-term control of inflammation in COPD but do not specifically address acute bacterial infections. Bronchodilators help to relieve airway constriction and improve breathing, but they do not target the infectious cause of symptom exacerbation. Oral corticosteroids can be beneficial in reducing inflammation during an exacerbation, but they do not have the same direct effect on bacterial infections as antibiotics do.

Therefore, in cases where a patient with COPD is experiencing increased purulent sputum production, the administration of antibiotics is the most appropriate and effective treatment option to manage the exacerbation properly.